Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic · Tablet

Tolvaptan 30 mg tablet price what pharmacies pay, and what you should

There is no weekly pharmacy acquisition cost for tolvaptan 30 mg tablet this week. The makers, package codes, recalls and label are below.

What did you pay for tolvaptan 30 mg tablet? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

No shortage reportedChecked Nov 17, 2026
No ongoing recalls1 recall on record, latest Apr 29, 2015

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

5 companies sell tolvaptan 30 mg tablet under 8 package codes (NDCs).

All 8 package codes

1 older package code is still priced but no longer in the current FDA listing.

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

Other tolvaptan strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
15 mg tablet$11.78$353.29 / 30 tablets-19.2%-68.0%

Official label & what changed

Last changedSeptember 9, 2022
Version10 of 4
EffectiveSep 7, 2022
Read the label

These highlights do not include all the information needed to use TOLVAPTAN TABLETS safely and effectively. See full prescribing information for TOLVAPTAN TABLETS. TOLVAPTAN tablets, for oral use Initial U.S. Approval: 2009

This drug has a boxed warning

WARNING: (A) INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM (B) NOT FOR USE FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

(A) Initiate and re-initiate in a hospital and monitor serum sodium

Tolvaptan tablets should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely.

Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable.

(B) Not for use for autosomal dominant polycystic kidney disease (ADPKD)

Because of the risk of hepatotoxicity, tolvaptan should not be used for ADPKD outside of the FDA-approved REMS [see Contraindications (4)].

WARNING: (A) INITIATE AND RE-INITIATE IN A HOSPITAL AND MONITOR SERUM SODIUM (B) NOT FOR USE FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

See full prescribing information for complete boxed warning.

(A) Initiate and re-initiate in a hospital and monitor serum sodium

Tolvaptan tablets should be initiated and re-initiated in patients only in a hospital where serum sodium can be monitored closely.

Too rapid correction of hyponatremia (e.g., >12 mEq/L/24 hours) can cause osmotic demyelination resulting in dysarthria, mutism, dysphagia, lethargy, affective changes, spastic quadriparesis, seizures, coma and death. In susceptible patients, including those with severe malnutrition, alcoholism or advanced liver disease, slower rates of correction may be advisable.

(B) Not for use for autosomal dominant polycystic kidney disease (ADPKD)

Because of the risk of hepatotoxicity, tolvaptan should not be used for ADPKD outside of the FDA-approved REMS (4)

Recent major changes (as listed on the label)

Warnings and Precautions (5.5, 5.7) 04/2021

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about tolvaptan 30 mg tablet

Who makes tolvaptan 30 mg tablet?

5 companies: Apotex Corp., Ascend Laboratories, LLC, Camber Pharmaceuticals, Inc., Novadoz Pharmaceuticals LLC, Par Health USA, LLC. See every package code.

Is tolvaptan in shortage?

No shortage is reported right now. We check every day.

Has tolvaptan been recalled?

1 recall on record. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about tolvaptan 30 mg tablet

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.